Trials / Completed
CompletedNCT07049562
Study on the Mass Balance of [14C]HRS-8427 for Injection in Healthy Chinese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the absorption, metabolism and excretion after a single intravenous infusion of \[14C\]HRS-8427 in healthy Chinese subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-8427 | \[14C\] HRS-8427 for injection |
Timeline
- Start date
- 2025-05-21
- Primary completion
- 2025-06-18
- Completion
- 2025-06-18
- First posted
- 2025-07-03
- Last updated
- 2025-07-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07049562. Inclusion in this directory is not an endorsement.